The female participants with NAFLD were older, had lower HDL cholesterol and eGFR, and higher SBP, DBP, prevalence rates of diabetes, hypertension, hyperlipidemia and MetS, and higher AST, ALT, fasting glucose, TG, LDL cholesterol, uric acid, BMI, WHtR, WHR, LAP, BRI, CI, VAI, BAI, AVI, TyG index, and HSI compared to the female participants without NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.